Please login to the form below

Not currently logged in
Email:
Password:

Novo Nordisk’s chief of staffs to leave

Company reduces number of executives from seven to six
Lise Kingo, Novo Nordisk

Novo Nordisk has decided to reduce the number of its executives from seven to six resulting in the departure of its chief of staffs Lise Kingo.

Kingo's responsibilities will be split among the remaining executives, including Lars Fruergaard Jørgensen, Jakob Riis and CEO Lars Rebien Sørensen.

Sørensen said: "I would like to thank Lise for her many contributions to Novo Nordisk during her impressive career in the company. Of special note is her leadership in driving the company's strategy within sustainable development, corporate branding and public affairs, which has earned Novo Nordisk recognition as a respected global business.”

Kingo joined Novo in 1988 and worked her way up the ranks, being appointed senior VP in 1999 and then as executive VP and chief of staffs in 2002. Her other roles include chair of the board of Steno Diabetes Center and member of the board of Grieg Star Group.

27th November 2014

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
JPA Health

JPA Health is an award-winning public relations, marketing and advocacy firm known for sharing our clients’ commitment to making people...

Latest intelligence

Robust Review: COVID19 Assessment
See how our client utilized Rapid Payer Response (RPR) to stay informed and gain continuous insights during the recent global pandemic (COVID19)...
Human behaviour - Sept 21
All change – how untangling human behaviour can encourage better health
Driving better patient outcomes through clear, achievable practical steps that are underpinned by transparent evidence...
Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...